Pharmaceutical Technology, April 2022

April 03, 2022

An early formulation strategy for tablets that is simple and scalable is recommended to ensure fewer downstream problems.

April 03, 2022

The author introduces a practical approach to determining the best estimate of probability for passing multiple stage dissolution tests.

April 03, 2022

Although not easy to do, it is essential because excipients can affect drug-product safety and efficacy.

April 03, 2022

Experts discuss what data to consider when selecting a high-potential drug candidate and how AI can be harnessed in medicinal chemistry drug discovery.

April 03, 2022

Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.

April 02, 2022

Performing corrective action and preventive action (CAPA) activities is often necessary to investigate a manufacturing deviation and prevent it from reoccurring. Pharmaceutical Technology asked Joe O’Gorman, head of Global Operations at LZ Lifescience, a Cognizant Company, about the role technology plays in performing CAPAs.

April 02, 2022

Data may be used to improve (or remove) a corrective action/preventive action.

April 02, 2022

Effective cleaning and disinfection along with contamination controls are imperative when operating and utilizing a cleanroom.

April 02, 2022

The AMR Action Fund has made its first investments, marking an important step forward for the partnership to achieve its goal of bringing new treatments to the market for priority pathogens.

April 02, 2022

Pharmaceutical Technology spoke with Colleen Floreck, vice president, Global Marketing and Strategy, Catalent Cell and Gene Therapy about the specific requirements and challenges for expanding production of viral vectors.

April 02, 2022

The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.

April 02, 2022

Meeting patient needs and achieving high quality are common goals for all stakeholders.

April 02, 2022

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.

April 02, 2022

In January 2022, Europe started to implement EU-CTR, a new regulatory framework for clinical trials, but what does this mean for pharma clinical research?

April 02, 2022

Innovations address supply-chain constraints, serialization, and new requirements for sustainable and patient-centric designs.

April 02, 2022

Quality metrics and more domestic production aim to avoid supply disruptions and drug shortages.

April 02, 2022

3D cell cultures could provide key avenues to unlocking critical information.

April 02, 2022

Experts Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Steven J. Lynn, executive vice-president, Pharmaceuticals for Regulatory Compliance Associates, discuss the verification of compendial methods.

April 02, 2022

ROSS Batch High Shear Mixers are a versatile tool for powder delivery and dispersion of low-viscosity liquids.

April 02, 2022

The PureVessel series provides modular storage, preparation, treatment, and mixing of liquids.

April 02, 2022

The DynaPro NanoStar II introduces advanced walk-up capabilities in DLS technology.

April 02, 2022

Rockwell Automations newest graphic terminals increase user storage, product security, and support for modern peripherals.

April 02, 2022

Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.